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Chronic renal insufficiency is characterized by
profound alterations in the orderly metabolic se-
quences which normally guarantee cellular integrity
and metabolic homeostasis. Hormonal imbalances
which contribute to these acquired defects include
abnormal growth hormone secretory patterns, ele-
vations in plasma aldosterone and glucagon, de-
creases in testosterone and thyroid hormone, and
defective biological degradation of cortisol, insulin,
and parathyroid hormone. These findings are often
coupled with blunted end-organ responsivity to hor-
monal stimulation, e.g., insulin, and contribute to
the disturbances in carbohydrate and lipid metabo-
lism and to defective synthesis and catabolism of
structural and enzymatic proteins. The normal kid-
ney functions as a biological filter by regulating the
excretion of a variety of substances, normally gen-
erated by either biological synthetic or degradative
reactions. These products can function as metabolic
"toxins" when retained by the body in sufficient
quantities.
The kidney also occupies a pivotal role in the reg-
ulation of calcium, inorganic phosphate, para-
thyroid hormone, calcitonin, and vitamin D metab-
olism. Adults and children with progressive loss of
renal parenchyma sustain derangements in mineral
and bone metabolism with resultant osteo-
dystrophy. Children experience abnormalities in
growth and remodeling of bone as well. These
changes may progress to a renal osteodystrophy
characterized by growth retardation and bone pain.
Hyperparathyroidisrn and deficiency in biological
activation of vitamin D are the basic patho-
physiologic mechanisms involved. The requirement
of vitamin 1) or its biologically more active forms is
increased. In this review, normal bone development
is described as a basis for interpreting the patho-
physiology of renal osteodystrophy in children. Be-
cause renal osteodystrophy is often termed "renal
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rickets" and the processes of osteodystrophy and
rickets differ, the evolution of the histological
changes of each are contrasted. Some of the ways
renal osteodystrophy affects growth are explained
by the evolution of these processes.
The unique features of childhood renal osteo-
dystrophy relate to distinctions between the effects
uremia has on the fully grown skeleton and growing
bone. Understanding the development of bone is
important to the understanding of bone disease and
growth retardation which occurs in children with
uremia.
Normal bone growth
Fetal bone development begins with clusters of
mesenchymal cells which differentiate into chon-
droblasts or osteoblasts. When chondroid dif-
ferentiation occurs, as is characteristic of long and
tubular bone development, a small cartilaginous
model of the adult bone is formed. This cartilage is
eventually replaced by osseous tissue. Hence, the
process is known as "endochondral ossification."
When, on the other hand, mesenchyrnal cells dif-
ferentiate into osteoblasts, as occurs in the flat
bones, e.g., skull, osseous tissue is synthesized di-
rectly in a process known as "intramembranous"
ossification.
Enchondral ossification, as occurs in long bones,
is achieved by an interplay between the physical
properties of the cartilaginous model and the bone
which replaces it. The process first occurs in the
diaphysis. It is characterized by chondrocyte hy-
pertrophy and ingrowth of blood vessels. Simulta-
neously, the adjacent perichondrium differentiates
into periosteum which in turn forms a collar of bone
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about the midshaft. This bone gradually encroaches
upon and replaces the diaphyseal cartilage. A simi-
lar, but not identical, process takes place at the
proximal and distal ends of the bone. Chondrocyte
hypertrophy and ultimate atrophy, followed by os-
seous encroachment, occur within ends of the carti-
laginous models but do not involve differentiation of
the adjacent perichondrium into periosteum. As
such, a collar of cartilage surrounds these ossifica-
tion centers which form the epiphyseal bone. The
cartilage between the ossification center and the
joint space develops into articular cartilage, while
that separating the epiphyseal and diaphyseal bone
forms the growth plate. This plate differentiates into
four distinct zones, the development of which re-
lates closely to longitudinal growth. Growth is
achieved by interstitial expansion of the growth
plate in zones juxtaposed to the epiphyseal ossifica-
tion center.
Interstitial growth, a property unique in the skele-
ton to cartilage, implies expansion of tissue mass by
replication of cells which have been incorporated
into the interstices of the structure, and matrix syn-
thesis by these internalized cells. Therefore, the
epiphyseal plate can increase in mass, despite the
absence of a free cartilaginous surface upon which
to layer additional cartilage. As the epiphyseal car-
tilage ages and moves towards the metaphysis, vas-
cular invasion of the tissue occurs, resulting in oxy-
genation and cell death. The most mature part of the
growth plate known as the "zone of provisional cal-
cification" is characterized by mineralization of the
cartilaginous matrix and its subsequent chondro-
clastic resorption. Those spicules of mineralized
cartilage which remain serve as a scaffolding for the
deposition of bone matrix. Consequently, in normal
endochondral ossification there is an integral ana-
tomical relationship between the primary bony tra-
beculae and the epiphyseal growth plate. This rela-
ti()nship has important implications in childhood
renal osteodystrophy. During normal growth, the
trabeculae are actively resorbed resulting in a di-
aphysis composed entirely of cortical bone. There-
fore, longitudinal growth is accomplished by expan-
sion of the growth plate at the ends of the bone and
resorption of the mineralized epiphyseal cartilage.
The width of the epiphyseal plate remains un-
changed, but it moves from the center of the long
bone. When growth ceases, cartilaginous resorption
exceeds formation, resulting in the gradual oblitera-
tion of the cartilaginous plate.
Intramembranous ossification, as opposed to
endochondral growth, is entirely appositional. This
type of bone development occurs predominantly in
flat bones and, similar to its endochondral counter-
part, originates with an accumulation of mesenchy-
mal cells. In intramembranous ossification, these
cells, however, differentiate directly into osteo-
blasts which form a spicule containing immature
"woven collagen." Continued apposition and ap-
propriate resorption results in a bone shaped similar
to its adult counterpart. During the third trimester
of gestation and in the first few years of life, virtual-
ly all "woven collagen" is resorbed and replaced by
mature lamellar bone. Periosteal growth and mod-
eling ceases coincidentally with epiphyseal closure.
The process of expansion of the width of long
bones is considered a component of endochondral
ossification. This process does not involve replace-
ment of a cartilaginous model but occurs by matrix
apposition at the periosteal surface and is more
closely akin to intramembranous bone formation.
When epiphyses close, periosteal bone synthesis
ceases; however, periosteal bone synthesis is reac-
tivated by diffuse or local pathological processes.
Pathogenesis of renal osteodystrophy in children
The pathogenesis of childhood renal osteo-
dystrophy and the attendent growth retardation can
be best appreciated with an understanding of the
four generic morphological functions of osteoblasts
and osteoclasts. These functions are growth, which
involves the increase in skeletal mass; modeling,
the process by which the small bones of a fetus are
shaped into their adult counterpart; remodeling, a
process intimately related to mineral homeostasis;
and repair, the prototype of which is fracture-heal-
ing.
Growth and modeling are unique to the growing
skeleton. The fact that these activities function in-
dependently is illustrated by diseases which effect
one to the exclusion of the others. For example, hy-
popituitary dwarfism is a dysfunction of growth,
while diaphyseal dysplasia or osteopetrosis may in-
volve only modeling. If one considers the growing
long bone a prototype, the functional distinction be-
tween growth and modeling becomes apparent. As
longitudinal growth progresses, the metaphysis,
which is characteristically a wide area of bone,
must be funnelled into the diaphysis. This requires
resorption and formation at specific foci necessary
to sculpture the bone. If modeling fails, the bone
often assumes a tubular character with little dis-
tinction between the diaphysis and metaphysis.
Remodeling, on the other hand, is a process which
occurs throughout life and is abnormal in both the
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uremic child and adult. The quintessential feature of
this process is the cybernetic coupling between
osteoblastic and osteoclastic activity [I]; i.e., where
osteoclastic resorption has occurred, osteoblastic
bone formation will invariably follow. Although
normal remodeling leaves residual histological
traces within relatively short periods of time, it does
not normally effect the gross architecture of the
bone. With aging, however, the site of the bone re-
sorption exceeds that of formation. Consequently
senescence is characterized by progressive loss of
bone and increased propensity to skeletal fracture
[2].
Although the pathogenesis and therapy of renal
osteodystrophy in adults has been the subject of nu-
merous reports and reviews [3—6J, analyses of the
underlying hormonal and metabolic defects which
initiate and perpetuate the skeletal abnormalities in
growing uremic children are relatively few. In
chronic renal failure of adults or children, intestinal
absorption of calcium is usually, but not always, de-
creased [3, 7—li] and circulating immunoreactive
PTH (iPTH) levels are usually elevated [12—14].
Hypocalcemia, hyperphosphatemia, hyperphos-
phatasia, and acidosis also occur. In some forms
of kidney disease, hypophosphatemia may be a
finding in the early phases of the disease. In chil-
dren, the level of circulating alkaline phosphatase
may be lower for the degree of skeletal involve-
ment, and circulating levels of calcium and phos-
phate bear little relationship to the growth rate or
histological defects noted on bone biopsied speci-
mens [15]. Serum iPTH may be elevated in uremic
children and adults without radiologic evidence of
bone disease, and it is generally elevated in over
90% of those who have detectable skeletal lesions
[12, 14]. Although compensatory parathyroid over-
activity (so-called secondary hyperparathyroidism)
appears to be more severe in children with long-
standing clinically demonstrable bone disease,
plasma iPTH returns to normal much sooner follow-
ing renal transplantation in children than in adults
[14]. The incidence of renal osteodystrophy is
greater in children and adolescents than it is in
adults [16]. The growing and rapidly remodeling
young skeleton has a high rate of osteoclastic ac-
tivity (i.e., high "bone-turnover"), and this may
make young bones more susceptible to alterations
in circulating PTH, 25-OH-D3, and 1,25(OH)2D3,
which occur during the course of progressive renal
insufficiency.
There are presently a limited number of recorded
observations regarding the effect of end-stage renal
disease on circulating 25-OH-D3 and 1 ,25(OH)2D3 in
children, although normal, low, or high plasma
25-OH-D3 values have been reported for adults with
renal failure [18—20] and dec:reased 1,25(OH)2D3
has been documented when glomerular filtration
rates fall below 40 toSO mllmin [21—31]. In two
10-yr-old children, who had severe end-stage renal
disease, l-hydroylation of administered tritiated 25-
OH-D3 was easily demonstrated 8 and 21 days
following successful renal homotranspiantation
[24]. The growing skeleton is extremely sensitive to
vitamin D depletion since vitamin D (and/or its
biologically active metabolites) is essential for
skeletal remodeling and endochondral bone forma-
tion at epiphyseal sites.
Athough the nature of the biochemical defect(s)
in the epiphyseal areas in humans is still virtually
unknown, the results of experimental studies in
rachitic and uremic animals may prove significant in
this regard. Bone collagen maturation is defective in
experimentally induced uremia [25]. Normal matu-
ration requires hydroxylation of lysine residues (ly-
syl-hydroxylase) in the collagen molecule to effect
proper cross-linking. An essenLtial cofactor for the
enzyme lysyl-hydroxylase is a-ketoglutarate [26], a
tricarboxcylic acid (TCA) cycle intermediate. Aero-
bic glycolysis also is a prerequisite for normal bone
matrix calcification [27, 28], and carbohydrate me-
tabolism in the normal epiphysis is predominantly
glycolytic in nature with minimal pentose shunt ac-
tivity [29]. In uremic rats, there is a shift in glucose
metabolism of epiphyseal cartilage from the normal
glycolytic to pentose shunt pathway, resulting in de-
fective production of a-ketoglutarate. This is cor-
rected by feeding 25-OH-D3 [30].
Another enzyme, lysyl-oxidase, also functions as
a pivotal enzyme in the maturation of skeletal and
epiphyseal collagen by catalyzing the synthesis of
cross-linked aldehyde precursors, the biochemical
step which immediately precedes the mineralization
of collagen [31, 32]. Recent preliminary studies re-
veal that vitamin D and/or one of its biologically ac-
tive metabolites stimulate lysyl-oxidase activity of
growth cartilage obtained from either rachitic
chicks or rats [331. To date, the relationship be-
tween the maturational defect in uremic rats that
shifts glucose metabolism from glycolytic to pen-
tose shunt activity [28] and its reversibility by vita-
min D treatment and the epiphyseal defects, growth
retardation, and vitamin D resistance of uremic
children is still uncertain and should be explored
further.
Renal osteodystrophy and azotemic rickets"
are more frequent and severe in children from Euro-
pean and Asian communities [34, 35]. This may re-
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fiect the relatively lower circulating levels of 25-
OH-D3 found in normal individuals in these same
geographical area [36, 37]. Where exposure to sun-
light is less and vitamin D supplementation of the
diet (i.e., at least 400 lU/day) is less commonly
practiced, rickets may be more common. On the
other hand, the incidence of radiographic osteo-
sclerosis and osteitis fibrosa is greater in uremic
children in North America [12, 38, 391.
Renal osteodystrophy is one of the causes of
growth retardation in children with uremia [401.
Other factors associated with growth retardation in
these children, such as acidosis, malnutrition, and
hormonal factors, may also act primarily on bone
(see also Lewy and VanWyk; Holliday and Chant-
ler, this issue). Fortunately, retardation of bone
growth is often accompanied by proportional retar-
dation of bone maturation, in which case the poten-
tial for achieving catch-up growth exists [401 (see
Potter and Greifer, this issue). By contrast, children
whose bone age has already reached 12 yr by the
time of renal transplantation rarely have significant
growth thereafter [411.
Comparison in bone pathology of childhood rickets and
renal osteodvstrophy
Apart from those involving the epiphyseal re-
gions, differences in bone pathology between adults
and children with uremia are few. Osteoscierosis,
osteoclastosis, and osteitis fibrosa are common in
younger individuals [42]. Severe cancellation of the
cortex occurs and results in loss of distinction be-
tween trabecular and compact bone [43]. Radio-
graphic abnormalities in the region of the growth
plate in childhood renal osteodystrophy, although
occasionally presenting as those characteristically
seen in nutritional rickets, may often be quite dis-
tinct. In the past, these changes have been in-
appropriately characterized as "rachitic," and they
are believed to be histologically indistinguishable
from those of nutritional rickets [44].
The histopathology of rickets due to vitamin D or
phosphate deficiency centers about abnormalities of
the growth plate. The characteristic features in-
clude failure of chondrocytes in the mineralization
of the zone of provisional calcification or devital-
ized cartilage bordering on the metaphysis. As a re-
sult, the width of the growth plate increases, and its
architecture becomes disarrayed. Despite this fail-
ure of mineralization, "woven collagen" is depos-
ited on these columns, resulting in formation of pri-
mary spongiosa. Due to failure of mineralization of
both the primary spongiosa and its cartilaginous
cores, there is failure of modeling, and the cartilage
persists within the deep metaphyseal bone. These
phenomena result in the radiographic changes of a
wide, overriding epiphysis with an irregular border
and absence of a line of provisional calcification.
The pathology of renal osteodystrophy in chil-
dren differs from that of rickets. Despite radio-
graphic similarities, the histologic changes in the
rachitic epiphysis differs from those in the uremic
epiphysis or growth plate. The growth plate in ure-
mia usually is not as thick, and in places it may be
thin. Its diameter in the horizontal plane, however,
generally is expanded and overrides the lateral
border of the metaphysis. Full-thickness rupture of
the growth plate may also occur. Histologically, the
chondrocytes of the epiphyseal plate in uremia are
arranged in grapelike clusters and their longitudinal
orientation lost. At the junction of the growth plate
and metaphysis, exuberant osteoclastic activity re-
sults from secondary hyperparathyroidism. Carti-
lage is reabsorbed and does not function as a lattice
upon which bone can be deposited.
Hyperparathyroidism also results in rnetaphyseal
fibrosis immediately beneath the growth plate. This
failure may interfere with vascular invasion of the
epiphyseal cartilage and hence development of the
primary spongiosa [43]. Metaphyseal trabeculae
form in a dysplastic fashion as spicules of woven
osteold within the subepiphyseal fibrous tissue.
This area is radiolucent and is usually misinterpret-
ed as representing an increase in the width of the
growth plate, a finding that is characteristic for defi-
ciency rickets. In some patients, a bony disc devel-
ops between the epiphyseal plate and metaphysis,
resulting in growth arrest and a loss of the inter-
locking connection between the epiphyseal growth
plate and metaphyseal bone. These lesions contrib-
ute to growth retardation and form a basis for the
development of genu valgum, and the slipped epiph-
ysis of the femorai head. Genti valgum and slipped
epiphyses also result from erosion of bone second-
ary to hyperparathyroidism. Slipped epiphyses are
more common in adolescents (i.e., 12 to 16 yr of
age) and seem to he precipitated by pubertal growth
spurt. Of note in this regard are observations docu-
menting severe secondary hyperparathyroidism in
growing children with endemic genu valgum [45].
Summary
The processes of growth and remodeling that
characterize growing bone are vulnerable to the bio-
chemical effects of uremia. These processes are af-
fected by the alterations in vitamin D metabolism
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and hyperparathyroidism that commonly occur
with chronic renal insufficiency. Uremia interferes
with cartilaginous developments as well. These
changes, which are similar radiographically to vita-
rnin-D-deficiency rickets, differ in their basic histo-
logical and biochemical evolution. They account for
growth failure and deformity of long bones, which
contribute to the short stature of children with renal
insufficiency.
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